Middleton D, Gillespie E L, Doherty C C, Douglas J F, McGeown M G
Transplantation. 1985 Jun;39(6):608-10. doi: 10.1097/00007890-198506000-00006.
HLA-DR matching has been shown in a retrospective study of 72 renal transplant patients to significantly enhance graft survival at 12 months. HLA-A and -B antigen matching also increased the graft survival rate significantly. Analysis of combined HLA-A, -B and -DR matching suggested an improvement in graft survival rate with better matching, but this did not attain statistical significance. It is now our policy to use HLA-DR matching prospectively and to ensure that all recipients receive a kidney with a maximum of 1 HLA-DR incompatibility and a minimum of 2 HLA-A and -B antigens shared.
一项针对72例肾移植患者的回顾性研究表明,HLA-DR配型可显著提高12个月时的移植物存活率。HLA-A和-B抗原配型也显著提高了移植物存活率。对HLA-A、-B和-DR联合配型的分析表明,配型越好,移植物存活率越高,但这未达到统计学意义。我们目前的策略是前瞻性地使用HLA-DR配型,并确保所有受者接受的肾脏与供者之间HLA-DR最多有1个不相容,且HLA-A和-B抗原至少有2个相同。